Quelicin Injection, Solution
Product Images NDC 0409-6629

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quelicin (NDC 0409-6629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Quelicin 01)

Chemical structure of Quelicin 20 mg/mL showing its molecular components including quaternary ammonium groups and associated chloride ions.*

FDA Label Image

Logo (Quelicin 02)

FDA Label Image

Principal Display Panel (20 mg/mL Vial Label)

Quelicin Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL) multi-dose vial label. The label includes warnings about its paralyzing effect and need for artificial respiration facilities. Contains preservatives methylparaben and propylparaben. Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.*

FDA Label Image

Principal Display Panel (20 mg/mL Vial Tray)

Packaging label for Quelicin 20 mg/mL (200 mg/10 mL) Succinylcholine Chloride Injection, USP. The label indicates a 10 mL multiple-dose vial, contains warning text about its paralyzing agent properties, and storage instructions to refrigerate between 2° to 8°C (36° to 46°F). The product is labeled Rx only and manufactured by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.